Registry of repeat pulsed-field ablation for atrial fibrillation
Part of Heart & circulation clinical trials.
This study is a registry that collects information from people who need a second pulsed-field ablation procedure for atrial fibrillation after a first one didn't work. By participating, you help doctors learn more about the safety and effectiveness of redoing this type of procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation (irregular heartbeat) and your doctor has recommended a pulsed-field ablation procedure to treat it.
- You are willing to sign a consent form (or your legal representative can do it for you).
- You are not enrolled in another research study that would interfere with this one (unless it's a purely observational registry).
- You can commit to attending follow-up visits and exams at the study center for the duration of the study.
- Your doctor estimates that your life expectancy is more than 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer ablation technique called pulsed field ablation to treat atrial fibrillation, a heart rhythm disorder. The goal is to see if this method works well and is safe for patients who need treatment.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This trial tests a new method called pulsed field ablation to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to safely stop AF episodes by targeting specific areas in the heart, and may help people with paroxysmal (coming and going) or persistent AF who haven't had this procedure before.
This study tests a new type of energy called pulsed field ablation to treat atrial fibrillation, an irregular heartbeat. It aims to see if it is safe and effective for people whose symptoms have not improved with medication.
This study tracks people who have a procedure called pulsed field ablation to fix an abnormal heart rhythm (atrial arrhythmia). It's a registry, meaning researchers will collect information to learn more about how well the treatment works and how safe it is.
This registry study collects information from people with atrial fibrillation (an irregular heartbeat) who are having a procedure using the PulseSelect PFA system. It helps doctors understand how well this treatment works in real-world settings.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.